Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

McComsey, Grace A; Kendall, Michelle A; Tebas, Pablo; Swindells, Susan; Hogg, Evelyn; Alston-Smith, Beverly; Suckow, Carol; Gopalakrishnan, Geetha; Benson, Constance; Wohl, David A

McComsey, Grace A; Kendall, Michelle A; Tebas, Pablo; Swindells, Susan; Hogg, Evelyn; Alston-Smith, Beverly; Suckow, Carol; Gopalakrishnan, Geetha; Benson, Constance; Wohl, David A.

Affiliation

McComsey GA; Rainbow Babies and Children's Hospital and Case Western Reserve University, Cleveland, Ohio, USA. gam9@case.edu

AIDS ; 21(18): 2473-82, 2007 Nov 30.

Article in En | MEDLINE | ID: mdl-18025884

Subject(s)

Alendronate/therapeutic use; Bone Density Conservation Agents/therapeutic use; HIV Infections/complications; Osteoporosis/drug therapy; Absorptiometry, Photon; Alendronate/adverse effects; Biomarkers/blood; Bone Density/drug effects; Bone Density Conservation Agents/adverse effects; Calcium/therapeutic use; Collagen Type I/blood; Drug Therapy, Combination; Female; Humans; Male; Osteoporosis/etiology; Osteoporosis/physiopathology; Peptides/blood; Prospective Studies; Risk Factors; Sex Factors; Treatment Outcome; Vitamin D/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Osteoporosis / HIV Infections / Alendronate / Bone Density Conservation Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: AIDS Year: 2007 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links